Agricultural Biotechnology Market Size & Growth Forecast 2027–2036, By Segments (Organism, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Organism Segment Analysis: Plants (Largest Segment) vs Microbes (Fastest-Growing Segment)

The plants segment dominated the agricultural biotechnology market with a 44.63% share in 2026, driven by the increasing adoption of genetically modified crops, advanced breeding techniques, and biotechnology-based solutions to improve agricultural productivity. Plant biotechnology plays a significant role in developing crop varieties with enhanced resistance to pests, diseases, environmental stress, and changing climatic conditions. The growing need to strengthen food security, improve crop yields, and optimize agricultural resource utilization is encouraging farmers and agricultural producers to adopt biotechnology-derived plant varieties. Genetic engineering, genome editing, and tissue culture technologies are enabling the development of crops with improved nutritional characteristics, greater tolerance to drought and salinity, and enhanced resistance to biotic stresses. The segment also benefits from increasing investments in agricultural research and development, along with the growing application of molecular breeding techniques to accelerate crop improvement. Furthermore, rising pressure on agricultural systems to increase production while minimizing the environmental impact of farming is supporting demand for plant-based biotechnology solutions. Continued advancements in crop genetics, precision breeding, and plant tissue engineering are expected to strengthen the role of plants in agricultural biotechnology, particularly as producers seek resilient crop varieties capable of adapting to evolving agricultural and climatic challenges.

The microbes segment is expected to grow at the fastest pace, supported by increasing demand for sustainable agricultural inputs, biological crop protection, and microbial solutions that improve soil health and nutrient availability. Agricultural microorganisms, including beneficial bacteria, fungi, and other microbial agents, are increasingly being used as biofertilizers, biopesticides, and biostimulants to improve crop productivity while reducing reliance on conventional chemical inputs. Microbial biotechnology supports nutrient fixation, phosphorus solubilization, organic matter decomposition, and improved plant tolerance to environmental stresses, making it valuable for sustainable farming practices. Growing awareness of soil degradation, chemical residue concerns, and the environmental impact of intensive agricultural practices is encouraging the adoption of microbial-based agricultural solutions. Advances in microbial strain selection, fermentation technologies, formulation development, and biological delivery systems are improving product stability, field performance, and compatibility with existing farming operations. In addition, increasing interest in regenerative agriculture, integrated pest management, and environmentally responsible crop production is creating opportunities for microbial biotechnology. The growing development of targeted microbial consortia and precision biological inputs is further expanding their potential applications across different crops and soil conditions, supporting the increasing adoption of microbial solutions in modern agriculture.

Application Segment Analysis: Transgenic Crops & Animals (Largest Segment) vs Vaccine Development (Fastest-Growing Segment)

The transgenic crops and animals segment accounted for the largest share of the agricultural biotechnology market, with a 26.35% share in 2026, driven by the growing application of genetic engineering to improve agricultural productivity, enhance desirable traits, and address challenges associated with food production. Transgenic crops are developed to provide characteristics such as resistance to insect pests, tolerance to herbicides, improved nutritional composition, and greater resilience to environmental stresses. These traits can help farmers reduce crop losses, improve production efficiency, and optimize agricultural inputs under varying growing conditions. Genetic modification in agricultural animals also supports the development of desirable characteristics related to productivity, disease resistance, and animal health. Increasing demand for food, changing climatic conditions, and the need to improve the efficiency of agricultural production are encouraging continued research into transgenic technologies. Furthermore, advancements in gene transfer methods, molecular biology, and genetic characterization are improving the development and assessment of genetically modified organisms. The segment is also supported by ongoing investments in agricultural research, crop improvement programs, and biotechnology-based solutions designed to address specific production challenges. As agricultural producers seek to improve crop performance, strengthen food supply resilience, and enhance resource efficiency, transgenic crops and animals continue to represent an important application of agricultural biotechnology, although adoption remains influenced by regulatory frameworks, public acceptance, and market-specific requirements.

The vaccine development segment is expected to grow at the fastest pace, driven by increasing demand for advanced animal healthcare solutions, improved disease prevention, and biotechnology-based approaches to livestock health management. Agricultural biotechnology supports the development of vaccines that help protect livestock and other farm animals against infectious diseases, reducing disease-related production losses and improving animal welfare. Advances in recombinant DNA technology, molecular biology, genetic engineering, and modern vaccine platforms are enabling the development of targeted vaccines with improved specificity and potential manufacturing efficiencies. The growing importance of livestock productivity, food safety, and disease control is encouraging agricultural producers and veterinary healthcare providers to strengthen preventive healthcare practices. In addition, the risk of emerging and re-emerging animal diseases is increasing the need for innovative vaccine development approaches that can support timely disease prevention and reduce the reliance on reactive treatment methods. Biotechnology-based vaccine research is also contributing to the development of improved immunization strategies, including vaccines designed to address complex pathogens and evolving disease threats. Increasing investments in veterinary biotechnology, animal health research, and disease surveillance are further supporting innovation in this application. As livestock production systems increasingly emphasize biosecurity, preventive care, and sustainable animal production, vaccine development is expected to gain greater importance in the agricultural biotechnology market.